COVID-19
NY
Doctors make decision-assisting bots for doctors
How We Help
Company Info
Clinical & IP
Clinical Validation
<p>As discussed in a previous section, we have initiated an extensive clinical trial of our software at Englewood Hospital to test avoMD’s usability as well as its impact on outcomes for preoperative cardiac risk assessment. The first phase of our testing focused on usability, where our app was received an 87 on the System Usability Scoring ("SUS") scale which ranks in the top 10% of usability for technology, beating Gmail.com (84 SUS) and Amazon.com (82 SUS). Additionally, 11 of 12 subjects agreed that the app was comprehensive enough to replace status quo tools. The next phase, a randomized control trial, was approved by an IRB in August and will measure impact on outcomes - specifically accuracy of diagnosis and physician efficiency. This phase is led by Dr. Sarah Collins (Columbia University Medical Center). </p> <p>We also have a preliminary agreement in place with a hospital in the Tristate area to initiate an IRB-approved clinical trial for our app in the neurology setting.</p>
IP Protection
—
Only accessible to MedStartr community members.
Join nowWhat do you think of COVID-19?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment